menu
    • menu

    Company profile for Delcath Systems

    NEW Drugs in Dev: 3
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. At Delcath, we look beyond the ordinary and strive for excellence in all that we do. Our investigational product, “Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System” (“Melphalan/HDS”), is designed to administer high-dose chemotherapy to the liver while minim...
    Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. At Delcath, we look beyond the ordinary and strive for excellence in all that we do. Our investigational product, “Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System” (“Melphalan/HDS”), is designed to administer high-dose chemotherapy to the liver while minimizing systemic exposure and associated side effects.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Delcath SystemsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1633 Broadway 22nd Floor, Suite C New York, NY 10019
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://delcath.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/delcath-systems-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Delcath Systems To Present At BTIG Medtech Conference
    Delcath Systems To Present At BTIG Medtech Conference

    27 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260127234456/en/Delcath-Systems-to-Participate-at-the-BTIG-13th-Annual-MedTech-Digital-Health-Life-Science-Diagnostic-Tools-Conference

    BUSINESSWIRE
    27 Jan 2026
    Share Share
    Delcath Systems Announces Inducement Grants Under Nasdaq Rules
    Delcath Systems Announces Inducement Grants Under Nasdaq Rules

    21 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260121436452/en/Delcath-Systems-Inc.-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    21 Jan 2026
    Share Share
    Delcath Systems Reveals 2025 Financial Results
    Delcath Systems Reveals 2025 Financial Results

    09 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260109101869/en/Delcath-Systems-Announces-Preliminary-Fourth-Quarter-and-Full-Year-2025-Financial-Results

    BUSINESSWIRE
    09 Jan 2026
    Share Share
    Delcath Systems Publishes Phase 3 FOCUS Study Subgroup Analyses
    Delcath Systems Publishes Phase 3 FOCUS Study Subgroup Analyses

    31 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251231288521/en/Delcath-Systems-Announces-Publication-of-Subgroup-Analyses-of-the-Phase-3-FOCUS-Study-of-MelphalanHepatic-Delivery-System-in-Patients-with-Unresectable-Metastatic-Uveal-Melanoma

    BUSINESSWIRE
    31 Dec 2025
    Share Share
    Delcath Announces 10-Year PHP Data for Liver-Dominant Tumors
    Delcath Announces 10-Year PHP Data for Liver-Dominant Tumors

    03 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251203718788/en/Delcath-Systems-Announces-Publication-of-10-Year-Single-Center-Experience-with-Percutaneous-Hepatic-Perfusion-in-Liver-Dominant-Metastatic-Uveal-Melanoma

    BUSINESSWIRE
    03 Dec 2025
    Share Share
    Delcath Systems Board Approves $25M Share Repurchase Program
    Delcath Systems Board Approves $25M Share Repurchase Program

    20 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251120794521/en/Delcath-Systems-Board-of-Directors-Authorizes-%2425-Million-Share-Repurchase-Program

    BUSINESSWIRE
    20 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search